Cutaneous lymphomas other than mycosis fungoides in Singapore: A clinicopathological analysis using recent classification systems

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 542-553

  Tan, S H ^a   Sim, C S ^b   Ong, B H ^c  

^a NATIONAL SKIN CENTRE   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Classification; Cutaneous; Lymphomas; Non mycosis fungoides; Singapore

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CHLORAMBUCIL; LEUKOSIALIN; METHOTREXATE; MONOCLONAL ANTIBODY CD3; OKT 4; OKT 8; PARAFFIN; PREDNISOLONE; PSORALEN;

ADOLESCENT; ADULT; AGED; ANGIOCENTRIC LYMPHOMA; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CELL INFILTRATION; CHILD; CORRELATION ANALYSIS; CUTANEOUS T CELL LYMPHOMA; DERMIS; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; GASTROINTESTINAL HEMORRHAGE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; NATURAL KILLER T CELL LYMPHOMA; PRIORITY JOURNAL; PUVA; SINGAPORE; SUBCUTANEOUS PANNICULITIS LIKE T CELL LYMPHOMA; SURVIVAL TIME; SYSTEMIC DISEASE; T CELL LEUKEMIA; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SINGAPORE;

EID: 0142120547     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05476.x     Document Type: Article

References (35)

1. Burg G, Kempf W, Haeffner AC et al. Cutaneous lymphomas. Curr Probl Dermatol 1997; 9: 137-204.
2. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
3. Zackheim HS, Vonderheid EC, Ramsay DL et al. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000; 43: 793-6.
4. Gilliam AC, Wood GS. Primary cutaneous lymphomas other than mycosis fungoides. Semin Oncol 1999; 26: 290-306.
5. Mukai K, Sato Y, Watanabe S et al. Non-Hodgkin lymphoma of the skin excluding mycosis fungoides and cutaneous involvement of adult T-cell leukemia/lymphoma. J Cutan Pathol 1988; 15: 193-200.
6. Nagasawa T, Miwa H, Nakatsuka S et al. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer Classification. Am J Dermatopathol 2000; 22: 510-14.
7. Ko YH, Kin CW, Park CS et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists; Revised European-American lymphoma. Cancer 1998; 83: 806-12.
8. Liang R, Chiu E, Loke SL et al. Primary and secondary cutaneous lymphomas in Hong Kong Chinese. Hematol Oncol 1990; 8: 333-8.
9. George R, Bhuvana S, Nair S, Lakshmana J. Clinicopathological profile of cutaneous lymphomas - a 10 year retrospective study from south India. Indian J Cancer 1999; 36: 109-19.
10. Sng I, Levin A, Jaffe ES et al. T-cell lymphoma in Singapore: pathology, clinical findings and association with HTLV-1 antibodies. Histopathology 1992; 21: 101-13.
11. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumors. In: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H, Vardiman JW, eds). Lyon: IARC Press, 2001.
12. Grange F, Hedelin G, Joly P et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. Blood 1999; 93: 3637-42.
13. Fink-Puches R, Zenahlik P, Back B et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in large group of patients. Blood 2002; 99: 800-5.
14. Wood GS, Burke JS, Horning S et al. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood 1983; 62: 464-72.
15. Ralfkiaer E, Saati TA, Bosq J et al. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides. J Clin Pathol 1986; 39: 553-63.
16. Mehregan DA, Su WP, Kurin PJ. Subcutaneous T-cell lymphoma: a clinical, histopathologic and immunohistochemical study of six cases. J Cutan Pathol 1994; 21: 110-17.
17. Salhany KE, Macon WR, Choi JK et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998; 22: 881-93.
18. Kumar S, Krenacs L, Medeiros J et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 1998; 29: 397-403.
19. Chan JK, Sin VC, Wong KF et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501-13.
20. Miyamoto T, Yoshino T, Takehisa T et al. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases. Br J Dermatol 1998; 139: 481-7.
21. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999; 40 (5 Pt 2): 850-6.
22. Cho KH, Choi WW, Youn CS et al. Skin is the frequent site for involvement of peripheral T-cell and natural killer cell lymphomas in Korea. J Dermatol 2000; 27: 500-7.
23. Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-61.
24. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996; 87: 1207-10.
25. Burg G, Dummer R, Dommann S et al. Pathology of cutaneous T-cell lymphoma. Hematol/Oncol Clin North Am 1995; 9: 961-95.
26. Glusac EJ, Kindel SE, Soslow RA, Smoller BR. Evaluation of classic architectural criteria in non-mycosis fungoides cutaneous lymphomas. Am J Dermatopathol 1997; 19: 557-61.
27. Willemze R, Beljaards RC. The spectrum of primary cutaneous CD30 (Ki-1) positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28: 973-80.
28. Beljaards RC, Kaudewitz P, Berti E et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study on 47 cases. Cancer 1993; 71: 2097-104.
29. Rijlaarsdam JU, Toonstra J, Meijer OWM et al. Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin. A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996; 14: 549-55.
30. Vermeer MH, van Geelen FAMJ, Haselen CW et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphomas with an intermediate prognosis. Arch Dermatol 1996; 132: 1304-8.
31. Marzano AV, Berti E, Paulli M, Caputo R. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma. Arch Dermatol 2000; 136: 889-96.
32. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol 2001; 23: 206-15.
33. Wang CYE, Su WPD, Kurtin PJ. Subcutaneous panniculitic T-cell lymphoma. Int J Dermatol 1996; 35: 1-8.
34. Jaffe ES. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains. Ann Oncol 1995; 6: 631-2.
35. Kawana F, Yamaguchi K, Nishimura H et al. Variation in the clinical courses of adult T-cell leukemia. Cancer 1985; 55: 851-6.